北方药学
北方藥學
북방약학
JOURNAL OF NORTH PHARMACY
2014年
5期
20-20,21
,共2页
妊娠期%贫血%复方硫酸亚铁叶酸片%妊娠结局
妊娠期%貧血%複方硫痠亞鐵葉痠片%妊娠結跼
임신기%빈혈%복방류산아철협산편%임신결국
Pregnancy%Anemia%Ompound ferrous sulfate folic acid tablets%Pregnancy outcomes
目的:分析复方硫酸亚铁叶酸片对孕妇贫血的临床疗效及妊娠结局。方法:采用复方硫酸亚铁叶酸片对治疗组缺铁性贫血孕妇进行治疗,同时对每名孕妇进行一对一的孕前保健及用药指导;对照组无一对一的孕前保健及用药指导,不服用任何铁剂药物;评价两组母婴结局。结果:治疗组总有效率显著高于对照组,红细胞、SF及Hb显著高于对照组,且在良好的孕前保健及用药指导下,该组妊娠期高血压、产后出血、低体重儿、新生儿窒息的发生率均明显低于对照组(P<0.05)。结论:孕前保健咨询及用药指导,联合复方硫酸亚铁叶酸片对贫血孕妇效果显著,无明显不良反应,值得推广。
目的:分析複方硫痠亞鐵葉痠片對孕婦貧血的臨床療效及妊娠結跼。方法:採用複方硫痠亞鐵葉痠片對治療組缺鐵性貧血孕婦進行治療,同時對每名孕婦進行一對一的孕前保健及用藥指導;對照組無一對一的孕前保健及用藥指導,不服用任何鐵劑藥物;評價兩組母嬰結跼。結果:治療組總有效率顯著高于對照組,紅細胞、SF及Hb顯著高于對照組,且在良好的孕前保健及用藥指導下,該組妊娠期高血壓、產後齣血、低體重兒、新生兒窒息的髮生率均明顯低于對照組(P<0.05)。結論:孕前保健咨詢及用藥指導,聯閤複方硫痠亞鐵葉痠片對貧血孕婦效果顯著,無明顯不良反應,值得推廣。
목적:분석복방류산아철협산편대잉부빈혈적림상료효급임신결국。방법:채용복방류산아철협산편대치료조결철성빈혈잉부진행치료,동시대매명잉부진행일대일적잉전보건급용약지도;대조조무일대일적잉전보건급용약지도,불복용임하철제약물;평개량조모영결국。결과:치료조총유효솔현저고우대조조,홍세포、SF급Hb현저고우대조조,차재량호적잉전보건급용약지도하,해조임신기고혈압、산후출혈、저체중인、신생인질식적발생솔균명현저우대조조(P<0.05)。결론:잉전보건자순급용약지도,연합복방류산아철협산편대빈혈잉부효과현저,무명현불량반응,치득추엄。
Objective:To analyze the clinical efficacy and pregnancy outcome of compound ferrous sulfate folic acid tablets on pregnant women with anemia. Methods: pregnant women with anemia were divided into the control group which were no given one-to-one preconception care and medication guide, had not taking any iron preparation and the treatment group which had taken compound ferrous sulfate folic acid tablets for the treatment of iron deficiency anemia and were given one-to-one preconception care and medication guide.then the pregnancy outcome were evaluated in the two groups. Results:The total effective rate of the treatment group with good preconception care and medication guide was significantly higher in RBC, SF and Hb than the control group. Gestational hypertension, postpartum hemorrhage, low birth weight children, newborn children asphyxia were significantly lower than the control group (P<0.05). Conclusion:preconception health counseling and medication guide, joint compound ferrous sulphate folic acid tablets had significant therapeutic effect on anemic pregnant women with no obvious adverse reaction, which were worthy of promotion.